Hatta, Y., Mizuta, S., Matsuo, K., Ohtake, S., Iwanaga, M., Sugiura, I., . . . Naoe, T. (2018). Final analysis of the JALSG Ph+ALL202 study: Tyrosine kinase inhibitor-combined chemotherapy for Ph+ALL. Ann Hematol.
Παραπομπή Chicago StyleHatta, Yoshihiro, et al. "Final Analysis of the JALSG Ph+ALL202 Study: Tyrosine Kinase Inhibitor-combined Chemotherapy for Ph+ALL." Ann Hematol 2018.
Παραπομπή MLAHatta, Yoshihiro, et al. "Final Analysis of the JALSG Ph+ALL202 Study: Tyrosine Kinase Inhibitor-combined Chemotherapy for Ph+ALL." Ann Hematol 2018.
Πρόσοχή: Οι παραπομπές μπορεί να μην είναι 100% ακριβείς.